Skip to main content

Table 3 Distribution of antiviral regimens among 334 HIV/HBV co-infected patients on current anti-HBV treatment

From: Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy

Treatment n (%)
TDF + LAM/FTC 235 70.4
LAM 60 18
TDF 17 5.1
Telbivudine 6 1.8
PEG-IFN § 6 1.8
Other combo NUC * 5 1.5
ETV 3 0.9
ADV 2 0.6
Total 334 100
  1. § + TDF = 4; *ADV + LAM =4, ADV + ETV =1.